Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Year Ending	Current	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	203	155	29	35	57	58
Market Cap Growth	431.50%	428.91%	-16.84%	-37.57%	-2.89%	-28.44%
Enterprise Value	208	160	25	30	56	61
PE Ratio	9.69	7.73	0.01	3.97	11.12	-26.01
PS Ratio	3.58	2.74	0.00	1.09	2.23	3.24
PB Ratio	3.52	2.70	1.01	1.40	3.50	5.47
P/FCF Ratio	-38.08	-37.97	-12.25	5.88	19.76	-31.86
P/OCF Ratio	-47.44	-47.34	8.80	5.43	17.72	-32.48
EV/Sales Ratio	3.67	2.83	0.00	0.92	2.20	3.40
EV/EBITDA Ratio	16.84	12.99	0.01	4.54	15.36	-80.17
EV/EBIT Ratio	19.22	14.83	0.01	5.83	26.49	-26.90
EV/FCF Ratio	-39.21	-39.11	-10.60	4.92	19.47	-33.44
Debt / Equity Ratio	0.14	0.14	0.13	0.11	0.15	0.38
Debt / EBITDA Ratio	0.95	0.95	0.00	0.43	0.66	-5.28
Debt / FCF Ratio	-2.86	-2.87	-1.62	0.46	0.83	-2.20
Quick Ratio	2.04	2.04	1.39	1.73	1.15	0.61
Current Ratio	3.07	3.07	2.75	2.82	2.10	1.19
Asset Turnover	0.82	0.68	835.17	0.92	0.97	0.72
Interest Coverage	17.17	18.33	-1.82	26.44	8.11	-6.42
Return on Equity (ROE)	34.92%	34.92%	15227.43%	35.28%	31.50%	-21.02%
Return on Assets (ROA)	24.04%	24.04%	10783.21%	25.32%	19.43%	-8.98%
Return on Capital (ROIC)	675.81%	675.81%	6821.05%	23.09%	13.94%	-15.56%
Earnings Yield	9.91%	12.94%	15012.72%	25.19%	8.99%	-3.85%
FCF Yield	-2.02%	-2.63%	-8.16%	17.01%	5.06%	-3.14%
Buyback Yield / Dilution	-2.81%	-1.02%	-0.23%	-7.17%	-13.30%	-1.96%
Total Shareholder Return	-2.81%	-1.02%	-0.23%	-7.17%	-13.30%	-1.96%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.